GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) and TerrAscend (OTCMKTS:TSNDF – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability.
Earnings and Valuation
This table compares GE HealthCare Technologies and TerrAscend”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| GE HealthCare Technologies | $20.62 billion | 1.82 | $2.08 billion | $4.74 | 17.50 |
| TerrAscend | $260.56 million | 0.46 | -$81.33 million | ($0.09) | -4.31 |
GE HealthCare Technologies has higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
82.1% of GE HealthCare Technologies shares are held by institutional investors. Comparatively, 5.8% of TerrAscend shares are held by institutional investors. 0.4% of GE HealthCare Technologies shares are held by insiders. Comparatively, 31.9% of TerrAscend shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Profitability
This table compares GE HealthCare Technologies and TerrAscend’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| GE HealthCare Technologies | 9.96% | 20.45% | 5.97% |
| TerrAscend | -28.96% | -30.76% | -4.89% |
Analyst Recommendations
This is a summary of current ratings and recommmendations for GE HealthCare Technologies and TerrAscend, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| GE HealthCare Technologies | 0 | 11 | 12 | 0 | 2.52 |
| TerrAscend | 0 | 1 | 0 | 0 | 2.00 |
GE HealthCare Technologies presently has a consensus target price of $82.17, suggesting a potential downside of 0.95%. Given GE HealthCare Technologies’ stronger consensus rating and higher probable upside, equities analysts plainly believe GE HealthCare Technologies is more favorable than TerrAscend.
Risk and Volatility
GE HealthCare Technologies has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Comparatively, TerrAscend has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500.
Summary
GE HealthCare Technologies beats TerrAscend on 12 of the 14 factors compared between the two stocks.
About GE HealthCare Technologies
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company’s products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
About TerrAscend
TerrAscend is a cannabis company that cultivates, processes and sells cannabis products through retail and wholesale channels. Its offerings include cannabis flower, pre-rolls, concentrates, edibles and other consumer products, sold under a portfolio of company and partner brands. The company operates in several U.S. markets, including Pennsylvania, New Jersey, Maryland, Michigan and California. Its retail business includes dispensaries operating under names such as The Apothecarium and Gage, alongside cultivation and processing facilities that supply its stores and other retailers.
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
